BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abad VC. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Nat Sci Sleep 2021;13:75-91. [PMID: 33531850 DOI: 10.2147/NSS.S245020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Arzt M. Schlafbezogene Atmungsstörungen – Update 2021. Somnologie. [DOI: 10.1007/s11818-022-00344-w] [Reference Citation Analysis]
2 Pavkovic IM, Kothare SV. Pharmacologic Approaches to Insomnia and Other Sleep Disorders in Children. Curr Treat Options Neurol. [DOI: 10.1007/s11940-022-00712-9] [Reference Citation Analysis]
3 Romigi A, Feola T, Cappellano S, De Angelis M, Pio G, Caccamo M, Testa F, Vitrani G, Centonze D, Colonnese C, Esposito V, Jaffrain-rea M. Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update. Front Neurol 2022;12:817257. [DOI: 10.3389/fneur.2021.817257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 El-Solh AA, Rudraraju A, Pasrija D, Bui H. Pharmacotherapy of residual excessive sleepiness among continuous positive airway pressure (CPAP) treated patients with sleep apnea. Expert Opin Pharmacother 2022;:1-10. [PMID: 35045769 DOI: 10.1080/14656566.2022.2029408] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ishikawa O, Hahn S, Greenberg H; Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA, Northwell Sleep Disorders Centre, Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine, Hofstra-Northwell, Northwell Health, NY, USA. Pharmacologic Therapy for Narcolepsy. Neurology 2022;18:68. [DOI: 10.17925/usn.2022.18.1.68] [Reference Citation Analysis]
6 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
7 Mehra R, Heinzer R, Castillo P. Current Management of Residual Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea: Insights for Optimizing Patient Outcomes. Neurol Ther 2021;10:651-72. [PMID: 34658002 DOI: 10.1007/s40120-021-00289-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Krief S, Berrebi-Bertrand I, Nagmar I, Giret M, Belliard S, Perrin D, Uguen M, Robert P, Lecomte JM, Schwartz JC, Finance O, Ligneau X. Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol. Pharmacol Res Perspect 2021;9:e00855. [PMID: 34423920 DOI: 10.1002/prp2.855] [Cited by in F6Publishing: 3] [Reference Citation Analysis]